Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Double-formula medicine used for treating insomnia, and preparation method thereof

A technology for insomnia and prescription, applied in drug combinations, medical preparations containing active ingredients, medical raw materials derived from mollusks, etc., can solve problems such as inability to achieve, slow movement, tremors, etc., and achieve the elimination of toxin residues , the effect of adjusting the dynamic balance and reducing the production cost

Active Publication Date: 2012-04-25
EMEISHAN HONGSHENG PHARMA
View PDF5 Cites 23 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the existing Western medicine treatment for insomnia and depression mainly suppresses the brain nervous system, which not only cures but also causes disease. Common side effects include dry mouth, obesity, lactation, blurred vision, weakness, slow movement, muscle tremors, and even dysphagia. , respiratory movement disorders and other symptoms
[0003] None of the existing drugs for the treatment of insomnia can achieve the effect of tonifying the kidney, soothing the liver and calming the nerves at the same time; they cannot achieve multi-target effects such as regulating the viscera, promoting the five viscera to settle down, removing toxin residues, regulating the dynamic balance of central neurotransmitters, and improving immunity. Treatment of all kinds of insomnia and depression through point, multi-link and multi-way
And the existing drug treatment can not fully reach the effect of safety, non-toxic and side effects, instant effect and complete treatment.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] First, extracts of various substances are obtained, and the extraction steps of the extracts are as follows:

[0033] (1) Remove impurities from the substances that need to be extracted; such as the extract of tai wu medicine, take out the medicinal part of tai wu medicine;

[0034] (2) Pulverize the material from which impurities have been removed; that is, pulverize it to 20 meshes through a pulverizer;

[0035] (3) Put it in the extraction tank according to the ratio of 1Kg of tai wu yao to 10L of water, and reflux for 20-30 minutes to obtain the extract; the extraction temperature is 100°C;

[0036] (4) Pump the extract into a concentration tank, concentrate the extract, and concentrate the extract at about 90°C using a conventional concentration method in the field of traditional Chinese medicine;

[0037] (5) The concentrated extract is spray-dried to obtain the tai wu medicine extract.

[0038] Various extracts in formula A and formula B are all obtained by the...

Embodiment 2

[0044] The difference between this embodiment and embodiment 1 is that the weight parts of recipe A and recipe B are different.

[0045] Prescription A: 1 part of Taiwu medicine extract, 2 parts of Danshen extract, 2 parts of Yuanhu extract, 3 parts of Panax notoginseng powder, 2 parts of Clematis clematis extract, 4 parts of black aconite, 3 parts of Eucommia extract, 1 part of Achyranthes knuckle extract, 1 part of Bupleurum extract, 3 parts of Chuanxiong extract, 3 parts of Wulingzhi, 2 parts of pearl powder, 2 parts of artificial bezoar, 18 parts of Ganoderma lucidum spore powder, 10 parts of chitosan oligosaccharide, Sophora flavescens 5 parts of extract, 1 part of grape seed extract, 4 parts of resveratrol extract, 5 parts of ginseng extract, 7 parts of epimedium extract, 7 parts of desmodium extract, 23 parts of Hedyotis diffusa extract , Banzhilian extract 11 parts, vitamin C1 part,

[0046] Recipe B: 13 parts of raw hawthorn extract, 5 parts of fenugreek extract, 6 p...

Embodiment 3

[0048] The difference between this embodiment and embodiment 1 is that the weight parts of recipe A and recipe B are different.

[0049] Prescription A: 3 parts of Taiwu medicine extract, 2 parts of Danshen extract, 4 parts of Yuanhu extract, 2 parts of Panax notoginseng powder, 1 part of Clematis clematis extract, 3 parts of black aconite, 2 parts of Eucommia extract, 4 parts of Achyranthes knuckle extract, 2 parts of Bupleurum extract, 3 parts of Chuanxiong extract, 2 parts of Wulingzhi, 1 part of pearl powder, 4 parts of artificial bezoar, 23 parts of Ganoderma lucidum spore powder, 10 parts of chitosan oligosaccharide, Sophora flavescens 5 parts of extract, 2 parts of grape seed extract, 3 parts of resveratrol extract, 6 parts of ginseng extract, 5 parts of epimedium extract, 12 parts of desmodium extract, 28 parts of Hedyotis diffusa extract , Banzhilian extract 13 parts, vitamin C 4 parts,

[0050] Recipe B: 9 parts of raw hawthorn extract, 8 parts of fenugreek extract,...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Diameteraaaaaaaaaa
Login to View More

Abstract

The invention discloses a double-formula medicine used for treating insomnia, and a preparation method thereof. With existing insomnia-treating medicines, a simultaneous kidney invigorating, liver soothing and tranquilizing function can hardly be achieved. The medicine assists in solving the problem. With the medicine, various depressive insomnias can be treated with multiple targets, multiple links and multiple approaches. The double-formula medicine provided by the invention is composed by a formula A and a formula B. The formula A is composed of a Tiantai radix linderae extract, a corydalis tuber extract, panax notoginseng powder, a Chinese clematis root and rhizome extract, black common monkshood daughter root, an eucommia extract, and the like. The formula B is composed of a white mulberry root-bark extract, a psoralea corylifolia extract, a dipsacus asper extract, a silktree albizia bark extract, an oriental waterplantain tuber extract, an asiatic plantain seed extract, a Chinese arborvilae seed extract, a thinleaf milkwort root extract, a spine date seed extract, a common cnidium fruit extract, and the like. The invention also provides a preparation method of the double-formula medicine. With the method, various depressive insomnias can be treated with multiple targets, multiple links and multiple approaches. The medicine is advantaged in safe treatment, no toxic or side effect, fast effect, and thorough treatment.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition for treating insomnia, specifically a double-prescription medicine using Chinese herbal medicine as a raw material for treating insomnia, and also relates to a preparation method of the medicine. Background technique [0002] The theory of traditional Chinese medicine believes that people are hurt by the seven emotions, namely joy, anger, worry, thought, sadness, fear, and shock, which lead to the disharmony of qi and blood, yin and yang, and dysfunction of viscera, so that the mind is disturbed, and the mind is absent and insomnia. Insomnia and depression in traditional Chinese medicine visceral disorders are mainly manifested in disharmony between the heart and the kidney, lack of nourishment of the mind, and liver failure to dredge and vent. The immune disorder of the body is an important factor in the induction and aggravation of insomnia and depression. The functional changes of t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/90A61K36/87A61K9/16A61K9/20A61P25/20A61K31/375A61K31/05A61K35/24A61K35/413A61K35/56A61K35/618
Inventor 余泽民刘芳郑鹰刘玉琴刘志刚
Owner EMEISHAN HONGSHENG PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products